Yasuaki Anami

Also affiliated with Brown Foundation, Green Cross International, The University of Texas Health Science Center at Houston

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors”.

Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.23.474044

N/A

0DataRank · unranked

0 citations

Yoshihiro Otani, Wei Xiong, Summer Y.Y. Ha, Aiko Yamaguchi, Ningyan Zhang +4 more

Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors

Cell Reports(2022)10.1016/j.celrep.2022.110839

N/A

0DataRank · unranked

48 citations

Yoshihiro Otani, Wei Xiong, Summer Y.Y. Ha, Aiko Yamaguchi, Kimberly Rivera-Caraballo +5 more

Exploring the next generation of antibody–drug conjugates

Nature Reviews Clinical Oncology(2024)10.1038/s41571-023-00850-2

N/A

0DataRank · unranked

570 citations

Yasuaki Anami, Summer Y.Y. Ha, Chisato M. Yamazaki, Kyoji Tsuchikama

A cytotoxic peptide-drug conjugate for tumor-specific delivery of co-injected molecules

PLoS ONE(2025)10.1371/journal.pone.0331564

N/A

0DataRank · unranked

0 citations

Chisato M. Yamazaki, Yasuaki Anami, Kyoji Tsuchikama, Kazuki N. Sugahara, Norio Miyamura